Increased amino acids levels and the risk of developing of hypertriglyceridemia in a 7-year follow-up

Journal of Endocrinological Investigation

Volumn 37, Issue 4, 2014, Pages 369-374

  Mook Kanamori, D O ^a,b   Romisch Margl W ^c   Kastenmuller G ^c   Prehn, C ^c   Petersen, A K ^c   Illig, T ^d   Gieger, C ^c   Wang Sattler, R ^c   Meisinger, C ^c   Peters, A ^c   Adamski, J ^c,e   Suhre, K ^a,c  

^a WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Amino acids; Hypertriglyceridemia

Indexed keywords

AMINO ACID; ARGININE; ISOLEUCINE; LEUCINE; LYSINE; PHENYLALANINE; PROLINE; TRIACYLGLYCEROL; VALINE; BETAINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BODY MASS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PREDICTIVE VALUE; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; DIET RESTRICTION; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC; RISK;

AGED; AMINO ACIDS; ARGININE; BETAINE; BODY MASS INDEX; FASTING; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; ISOLEUCINE; LEUCINE; MALE; MIDDLE AGED; ODDS RATIO; PHENYLALANINE; PROLINE; RISK FACTORS; ROC CURVE; TRIGLYCERIDES; VALINE;

EID: 84900527122     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/s40618-013-0044-7     Document Type: Article

References (22)

1. Miller M, Stone NJ, Ballantyne C et al (2011) Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 123:2292-2333
2. Kathiresan S, Willer CJ, Peloso GM et al (2009) Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 41:56-65
3. Johansen CT, Kathiresan S, Hegele RA (2011) Genetic determinants of plasma triglycerides. J Lipid Res 52:189-206
4. Suhre K, Shin SY, Petersen AK et al (2011) Human metabolic individuality in biomedical and pharmaceutical research. Nature 477:54-60
5. Zhai G, Wang-Sattler R, Hart DJ et al (2010) Serum branched-chain amino acid to histidine ratio: a novel metabolomic biomarker of knee osteoarthritis. Ann Rheum Dis 69:1227-1231
6. Rhee EP, Cheng S, Larson MG et al (2011) Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Investig 121:1402-1411
7. Wang TJ, Larson MG, Vasan RS et al (2011) Metabolite profiles and the risk of developing diabetes. Nat Med 17:448-453
8. Floegel A, Stefan N, Yu Z et al (2013) Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 62:639-648. http://www.ncbi.nlm.nih.gov/pubmed/23043162
9. Wang-Sattler R, Yu Z, Herder C et al (2012) Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol 8:615
10. Krebs M, Krssak M, Bernroider E et al (2002) Mechanism of amino acid-induced skeletal muscle insulin resistance in humans. Diabetes 51:599-605
11. Felig P, Marliss E, Cahill GF Jr (1969) Plasma amino acid levels and insulin secretion in obesity. N Engl J Med 281:811-816
12. Huang Y, Zhou M, Sun H, Wang Y (2011) Branched-chain amino acid metabolism in heart disease: an epiphenomenon or a real culprit? Cardiovasc Res 90:220-223
13. Holle R, Happich M, Lowel H, Wichmann HE (2005) KORA - a research platform for population based health research. Gesundheitswesen 67(Suppl 1):S19-S25
14. Rathmann W, Strassburger K, Heier M et al (2009) Incidence of type 2 diabetes in the elderly German population and the effect of clinical and lifestyle risk factors: KORA S4/F4 cohort study. Diabet Med: J Br Diabet Assoc 26:1212-1219
15. Illig T, Gieger C, Zhai G et al (2010) A genome-wide perspective of genetic variation in human metabolism. Nat Genet 42:137-141
16. Jourdan C, Petersen AK, Gieger C et al (2012) Body fat free mass is associated with the serum metabolite profile in a population-based study. PLoS One 7:e40009
17. U.S. Department of Health and Human Services FaDA CfDE-aRC, Center for Veterinary Medicine (CVM) (2001) Guidance for industry. Bioanalytical method validation
18. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK (1990) Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 263:2893-2898
19. D'Agostino RB Jr, Hamman RF, Karter AJ, Mykkanen L, Wagenknecht LE, Haffner SM (2004) Cardiovascular disease risk factors predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes Care 27:2234-2240
20. Newgard CB, An J, Bain JR et al (2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9:311-326
21. Mihalik SJ, Goodpaster BH, Kelley DE et al (2010) Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. Obesity 18:1695-1700
22. Schooneman MG, Vaz FM, Houten SM, Soeters MR (2013) Acylcarnitines: reflecting or inflicting insulin resistance? Diabetes 62:1-8